BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8372041)

  • 21. Gastrointestinal dialysis of disopyramide in healthy subjects.
    Arimori K; Kawano H; Nakano M
    Int J Clin Pharmacol Ther Toxicol; 1989 Jun; 27(6):280-4. PubMed ID: 2737797
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Congestive heart failure and toxic digoxin levels: role of cholestyramine.
    Roberge RJ; Sorensen T
    Vet Hum Toxicol; 2000 Jun; 42(3):172-3. PubMed ID: 10839325
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stereoselective gastrointestinal clearance of disopyramide in rabbits treated with activated charcoal.
    Huang JD
    J Pharm Sci; 1988 Nov; 77(11):959-62. PubMed ID: 3225758
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interaction of tricyclic antidepressants with cholestyramine in vitro.
    Bailey DN; Coffee JJ; Anderson B; Manoguerra AS
    Ther Drug Monit; 1992 Aug; 14(4):339-42. PubMed ID: 1519310
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of digoxin cross-reacting substances in patients with acute yellow Oleander (Thevetia peruviana) poisoning, including the effect of activated charcoal.
    Roberts DM; Southcott E; Potter JM; Roberts MS; Eddleston M; Buckley NA
    Ther Drug Monit; 2006 Dec; 28(6):784-92. PubMed ID: 17164695
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cholestyramine and digoxin intoxication: therapeutic efficacy?].
    Frésard F; Balant L; Noble J; Garcia B; Muller AF
    Schweiz Med Wochenschr; 1979 Mar; 109(12):431-6. PubMed ID: 424712
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of cholestyramine on the pharmacokinetics of cerivastatin.
    Mück W; Ritter W; Frey R; Wetzelsberger N; Lücker PW; Kuhlmann J
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):250-4. PubMed ID: 9208341
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of amiodarone on the pharmacokinetics and toxicity of digoxin in laboratory animals.
    Staneva-Stoytcheva D; Kristeva E
    Acta Physiol Pharmacol Bulg; 1991; 17(4):37-42. PubMed ID: 1841516
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cholestyramine as an adsorbent in acute lindane poisoning: a murine model.
    Kassner JT; Maher TJ; Hull KM; Woolf AD
    Ann Emerg Med; 1993 Sep; 22(9):1392-7. PubMed ID: 7689801
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interruption of the enterohepatic circulation of digitoxin by cholestyramine. I. Protection against lethal digitoxin intoxication.
    Caldwell JH; Greenberger NJ
    J Clin Invest; 1971 Dec; 50(12):2626-37. PubMed ID: 5129314
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral bioavailability of digoxin is enhanced by talinolol: evidence for involvement of intestinal P-glycoprotein.
    Westphal K; Weinbrenner A; Giessmann T; Stuhr M; Franke G; Zschiesche M; Oertel R; Terhaag B; Kroemer HK; Siegmund W
    Clin Pharmacol Ther; 2000 Jul; 68(1):6-12. PubMed ID: 10945310
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The influence of cholestyramine on the elimination of tenoxicam and piroxicam.
    Guentert TW; Defoin R; Mosberg H
    Eur J Clin Pharmacol; 1988; 34(3):283-9. PubMed ID: 3260866
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of intragastrically administered digoxin in rabbits with experimental bile duct obstruction.
    Wójcicki M; Drozdzik M; Sulikowski T; Gawronska-Szklarz B; Wójcicki J; Rózewicka L; Skowron J; Zielinski S; Musial HD; Zakrzewski J
    J Pharm Pharmacol; 1997 Nov; 49(11):1082-5. PubMed ID: 9401942
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced elimination of warfarin during treatment with cholestyramine.
    Jähnchen E; Meinertz T; Gilfrich HJ; Kersting F; Groth U
    Br J Clin Pharmacol; 1978 May; 5(5):437-40. PubMed ID: 656283
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of cholestyramine and activated charcoal on glipizide absorption.
    Kivistö KT; Neuvonen PJ
    Br J Clin Pharmacol; 1990 Nov; 30(5):733-6. PubMed ID: 2271372
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of amiodarone on the pharmacokinetics and toxicity of digoxin in laboratory animals.
    Staneva-Stoytcheva D; Kristeva E
    Methods Find Exp Clin Pharmacol; 1992 Apr; 14(3):193-7. PubMed ID: 1625503
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduction of absorption of paracetamol by activated charcoal and cholestyramine: a possible therapeutic measure.
    Dordoni B; Willson RA; Thompson RP; Williams R
    Br Med J; 1973 Jul; 3(5871):86-7. PubMed ID: 4717848
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparison between the effects of diltiazem and isosorbide dinitrate on digoxin pharmacodynamics and kinetics in the treatment of patients with chronic ischemic heart failure.
    Mahgoub AA; El-Medany AH; Abdulatif AS
    Saudi Med J; 2002 Jun; 23(6):725-31. PubMed ID: 12070557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of cholestyramine on absorption of 3H digoxin in rats.
    Thompson WG
    Am J Dig Dis; 1973 Oct; 18(10):851-6. PubMed ID: 4742358
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of amiodarone on oral and intravenous digoxin kinetics in healthy subjects.
    Santostasi G; Fantin M; Maragno I; Gaion RM; Basadonna O; Dalla-Volta S
    J Cardiovasc Pharmacol; 1987 Apr; 9(4):385-90. PubMed ID: 2438499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.